Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 16 February

Sophia Mavridis
February 16, 2022

Morning Bell 15 February

Paulina Peters
February 15, 2022

Morning Bell 14 February

Sophia Mavridis
February 14, 2022

Weekly Wrap 11 February

Sophia Mavridis
February 11, 2022

Morning Bell 10 February

Paulina Peters
February 10, 2022

Morning Bell 9 February

Sophia Mavridis
February 9, 2022

Morning Bell 8 February

Paulina Peters
February 8, 2022

Morning Bell 7 February

Sophia Mavridis
February 7, 2022

Weekly Wrap 4 February

Sophia Mavridis
February 4, 2022

Morning Bell 3 February

Paulina Peters
February 3, 2022